摘要 |
A gene profiling signature for predicting ovarian cancer patient survival is disclosed herein. The gene signature can be used to diagnosis or prognosis ovarian cancer, identify agents to treat an ovarian tumor, to predict the metastatic potential of an ovarian tumor and to determine the effectiveness of ovarian tumor treatments. Thus, methods are provided for diagnosing and prognosing an ovarian tumor, such as ovarian cancer, in a subject. Methods are also provided for identifying agents that can be used to treat an ovarian tumor, for determining the effectiveness of an ovarian tumor treatment, or to predict the metastatic potential of an ovarian tumor. Methods of treatment are also disclosed which include administering a composition that includes a specific binding agent that specifically binds to one of the disclosed ovarian survival factor-associated molecules and ovarian tumor in the subject. |
申请人 |
THE GOV. OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES;BIRRER, MICHAEL, J.;BONOME, TOMAS, A.;OZBUN, LAURENT, L.;MOK, SAMUEL |
发明人 |
BIRRER, MICHAEL, J.;BONOME, TOMAS, A.;OZBUN, LAURENT, L.;MOK, SAMUEL |